Mark Barron, MD
Orthopaedic Surgery · Hattiesburg, MSNPI 1255576377
Payments from drug & device makers
What this record shows
Stryker accounts for 64.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $777 and has fallen 81.1% since, to $147 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MS, where the typical reported total is $3,357.
Across 20 payments — averaging $58.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$764
- Ferring Pharmaceuticals Inc.$78
- Johnson & Johnson$74
- Zimmer Biomet$63
- ALON Medical Technology$47
- Radius Health, Inc.$40
- plus $112 from 5 others
What the payments were for
- Travel & lodging$64254%
- Food & beverage$53746%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $764 |
| Ferring Pharmaceuticals Inc. | 2 | $78 |
| Johnson & Johnson | 1 | $74 |
| Zimmer Biomet | 1 | $63 |
| ALON Medical Technology | 1 | $47 |
| Radius Health, Inc. | 3 | $40 |
| Sanara Medtech Inc. | 1 | $35 |
| Cerapedics Inc. | 1 | $25 |
| Spineology Inc. | 2 | $21 |
| Arteriocyte Medical Systems, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,180 in reported general payments places this provider in the 25th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 163 | $1,098 |
| Gabapentin | 112 | $699 |
| Methylprednisolone | 72 | $443 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $345 |
| Clindamycin Hcl | 21 | $147 |
| Meloxicam | 23 | $87 |
| Cephalexin | 15 | $61 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $59 |
| Famotidine | 27 | $37 |
| Cyclobenzaprine Hcl | 16 | $33 |
| Tramadol Hcl | 21 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hattiesburg
- Thomas RoyalsHattiesburg$10K
- Matthew GravesJackson$1.2M
- George van OstenTupelo$322K
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jamey BurrowJackson$130K
- Jeff AlmandJackson$109K
- Spencer MontgomeryJackson$90K
- Larry FieldJackson$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.